Senior insider sale
Exec. VP and CLO at PTC THERAPEUTICS, INC. — senior position signals high conviction
$640.6K
8.62K shares
What this filing means
BOULDING MARK ELLIOTT plans to sell 8.62K shares of PTC THERAPEUTICS, INC. valued at approximately $640.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/15/2026ACC: 0001959173-26-003630
Officer· Exec. VP and CLO
Since Jan 2019
8.62K
Shares to sell
$640.6K
Approx. market value
2.81K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Option Granted - 02/15/2024
Cash
5/15/2026
2.81KTotal acquired2.81K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Option Granted - 02/15/2024 Cash | 2.81K | — |
| Total | 2.81K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
3.54K
Market value
$279.6K
5/8/2026
—Completed
Units to sell
2.27K
Market value
$157.3K
4/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.81K
Market value
$203.7K
5/15/2026
Total
Units
8.62K
Value
$640.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/8/2026 | 3.54K | $279.6K | — | Completed |
4/6/2026 | 2.27K | $157.3K | — | Completed |
| Planned — Approximate Date | ||||
5/15/2026 | 2.81K | $203.7K | NASDAQ | Planned |
| Total | 8.62K | $640.6K | ||